ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 461 out of 6645

$769K Total Retail Price of All Prescriptions

Rank: 540 out of 6645

380 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 380 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 10,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 774 628 1 2
BENAZEPRIL HCL 747 626 2 21
DICLOFENAC SODIUM 504 420 3 109
OMEPRAZOLE 494 360 4 6
SIMVASTATIN 427 322 5 1
LOVAZA 363 260 6 68
METFORMIN HCL 344 293 7 7
JANUVIA 329 291 8 38
ALENDRONATE SODIUM 281 242 9 14
LEVOTHYROXINE SODIUM 259 206 10 4
ATENOLOL 256 208 11 8
COREG CR 239 205 12 242
ATORVASTATIN CALCIUM 232 200 13 10
HYDROCODONE-ACETAMINOPHEN 222 181 S3 14 5
FUROSEMIDE 221 205 15 11
CARVEDILOL 218 194 16 25
GLYBURIDE 193 163 R 17 58
TRAMADOL HCL 193 160 17 30
LOSARTAN POTASSIUM 191 158 19 12
METOPROLOL TARTRATE 179 156 20 13
GLIPIZIDE 149 127 21 23
HUMULIN 70-30 140 87 22 328
IBUPROFEN 137 96 23 42
DIOVAN 134 118 24 19
NIASPAN 134 116 24 164
HYDROCHLOROTHIAZIDE 133 94 26 9
WARFARIN SODIUM 130 116 27 16
ADVAIR DISKUS 130 101 27 45
ZETIA 125 96 29 87
ZOLPIDEM TARTRATE 124 116 30 17
INSULIN SYRINGE 120 76 31 61
DONEPEZIL HCL 119 118 32 27
CLONIDINE HCL 118 100 33 56
SINGULAIR 110 84 34 76
AZITHROMYCIN 102 83 35 44
AVODART 100 100 36 99
TAMSULOSIN HCL 92 92 37 22
NASONEX 88 62 38 126
FLUOCINONIDE 88 73 38 130
ACETAMINOPHEN-CODEINE 86 72 S3 40 80
LEVOFLOXACIN 85 65 41 83
LIPITOR 81 74 42 69
PATANOL 80 51 43 131
CLONIDINE 80 73 43 308
GABAPENTIN 77 54 45 18
SPIRIVA 77 69 45 65
DULERA 76 50 47 300
NITROFURANTOIN MONO-MACRO 73 58 48 233
MECLIZINE HCL 71 68 49 122
KETOCONAZOLE 71 54 49 196
PANTOPRAZOLE SODIUM 70 61 51 29
METOPROLOL SUCCINATE 69 69 52 24
FLUTICASONE PROPIONATE 69 45 52 26
MELOXICAM 61 38 54 46
NOVOLIN 70-30 58 40 55 309
RANITIDINE HCL 56 54 56 51
CYCLOBENZAPRINE HCL 54 38 R 57 157
CRESTOR 54 51 57 34
MONTELUKAST SODIUM 53 38 59 128
PLAVIX 52 44 60 49
MEGESTROL ACETATE 52 51 R 60 104
LISINOPRIL 50 38 62 3
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.